In addition to causing muscle hypertrophy, genetic interventions that activate Akt specifically in skeletal muscle also increase energy expenditure, reduce adiposity and blood glucose, and impart resistance to diet-induced obesity, glucose intolerance and fatty liver disease [8], [9]. The gene discussed is AKT1; the disease is Glucose intolerance.